Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.30 +3.60%
Revenue Growth %: -49.8%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -49.8%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported FY EPS of ($0.08). Revenue for the period came in at $52.74 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gulfport Energy and Mobility Global to join S&P SmallCap 600
- TEN Holdings prices $7.5 million common stock offering at $1 per share
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
